| Nanostructured antimicrobial peptides: The last push towards clinics JV Carratalá, N Serna, A Villaverde, E Vázquez, N Ferrer-Miralles Biotechnology advances 44, 107603, 2020 | 95 | 2020 |
| Biofabrication of functional protein nanoparticles through simple His-tag engineering H López-Laguna, JM Sanchez, JV Carratalá, M Rojas-Peña, ... ACS sustainable chemistry & engineering 9 (36), 12341-12354, 2021 | 21 | 2021 |
| Potential of MMP-9 based nanoparticles at optimizing the cow dry period: Pulling apart the effects of MMP-9 and nanoparticles L Gifre-Renom, JV Carratalá, S Parés, L Sánchez-García, ... Scientific reports 10 (1), 11299, 2020 | 15 | 2020 |
| Aggregation-prone peptides modulate activity of bovine interferon gamma released from naturally occurring protein nanoparticles JV Carratalá, O Cano-Garrido, J Sánchez, C Membrado, E Pérez, ... New biotechnology 57, 11-19, 2020 | 13 | 2020 |
| In vivo bactericidal efficacy of GWH1 antimicrobial peptide displayed on protein nanoparticles, a potential alternative to antibiotics JV Carratalá, E Brouillette, N Serna, A Sánchez-Chardi, JM Sánchez, ... Pharmaceutics 12 (12), 1217, 2020 | 11 | 2020 |
| The poly-histidine tag H6 mediates structural and functional properties of disintegrating, protein-releasing inclusion bodies JM Sánchez, JV Carratalá, N Serna, U Unzueta, V Nolan, ... Pharmaceutics 14 (3), 602, 2022 | 10 | 2022 |
| Design strategies for positively charged endolysins: insights into Artilysin development JV Carratalá, A Arís, E Garcia-Fruitós, N Ferrer-Miralles Biotechnology advances, 108250, 2023 | 9 | 2023 |
| Antibacterial activity of t22, a specific peptidic ligand of the tumoral marker cxcr4 N Serna, JV Carratalá, O Conchillo-Solé, C Martínez-Torró, U Unzueta, ... Pharmaceutics 13 (11), 1922, 2021 | 8 | 2021 |
| Selecting subpopulations of high-quality protein conformers among conformational mixtures of recombinant bovine mmp-9 solubilized from inclusion bodies JV Carratalá, L Gifre-Renom, R Roca-Pinilla, A Villaverde, A Arís, ... International journal of molecular sciences 22 (6), 3020, 2021 | 8 | 2021 |
| Developing Protein–Antitumoral Drug Nanoconjugates as Bifunctional Antimicrobial Agents N Serna, JV Carratalá, E Parladé, A Sánchez-Chardi, A Aviñó, U Unzueta, ... ACS Applied Materials & Interfaces 12 (52), 57746-57756, 2020 | 7 | 2020 |
| insoluble proteins catch heterologous soluble proteins into inclusion bodies by intermolecular interaction of aggregating peptides JV Carratalá, A Cisneros, E Hellman, A Villaverde, N Ferrer-Miralles Microbial cell factories 20, 1-10, 2021 | 4 | 2021 |
| Biofabrication of Self-Assembling Covalent Protein Nanoparticles through Histidine-Templated Cysteine Coupling H López-Laguna, A Rueda, C Martínez-Torró, L Sánchez-Alba, ... ACS Sustainable Chemistry & Engineering 11 (10), 4133-4144, 2023 | 3 | 2023 |
| Efficient Delivery of Antimicrobial Peptides in an Innovative, Slow-Release Pharmacological Formulation N Serna, H López-Laguna, P Aceituno, M Rojas-Peña, E Parladé, ... Pharmaceutics 15 (11), 2632, 2023 | 2 | 2023 |
| Enhanced recombinant protein capture, purity and yield from crude bacterial cell extracts by N-Lauroylsarcosine-assisted affinity chromatography JV Carratalá, J Atienza-Garriga, H López-Laguna, E Vázquez, ... Microbial cell factories 22 (1), 81, 2023 | 2 | 2023 |
| Toxicity profiling of bacterial inclusion bodies in human Caco-2 cells I Barguilla, U Unzueta, JV Carratalá, O Cano-Garrido, A Villaverde, ... Frontiers in Bioengineering and Biotechnology 10, 842256, 2022 | 2 | 2022 |
| Quality Control of Proteins Solubilized from Inclusion Bodies JM Sánchez, JV Carratalá, L Gifre-Renom, A Arís, E Garcia-Fruitós, ... Insoluble Proteins: Methods and Protocols, 469-477, 2022 | 1 | 2022 |
| L ys JEP 8: A promising novel endolysin for combating multidrug‐resistant G ram‐negative bacteria JV Carratalá, N Ferrer‐Miralles, E Garcia‐Fruitós, A Arís Microbial Biotechnology 17 (6), e14483, 2024 | | 2024 |
| Raw data to support the manuscript with the following scope: Efficient delivery of antimicrobial peptides in an innovative, slow-release pharmacological formulation A Villaverde Corrales, E Tejero Laguna, E Vazquez Gomez, U Unzueta, ... | | 2023 |
| A Novel Generation of Tailored Antimicrobial Drugs Based on Recombinant Multidomain Proteins A López-Cano, N Ferrer-Miralles, J Sánchez, JV Carratalá, XR Rodriguez, ... Pharmaceutics 15 (4), 1068, 2023 | | 2023 |
| A new method for the purification of recombinant proteins A Villaverde Corrales, E Tejero Laguna, E Vazquez Gomez, JV Carratalá, ... | | 2023 |
